What is the recommended surveillance for a 1 cm splenic artery aneurysm?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Surveillance of 1 cm Splenic Artery Aneurysm

For a 1 cm splenic artery aneurysm, conservative management with imaging surveillance is recommended, as this size is well below the 2 cm threshold for intervention. 1

Treatment Threshold and Risk Stratification

The ACC/AHA guidelines establish clear size-based criteria for visceral artery aneurysms:

  • Intervention is indicated for splenic artery aneurysms ≥2.0 cm in women of childbearing age (not currently pregnant) and patients undergoing liver transplantation 1
  • Intervention is probably indicated for aneurysms ≥2.0 cm in women beyond childbearing age and in men 1
  • Aneurysms <2.0 cm can be managed conservatively with surveillance imaging 1, 2

Your 1 cm aneurysm is half the size threshold for intervention, placing it in the low-risk category for rupture.

Recommended Surveillance Protocol

Perform imaging surveillance every 2-3 years for stable aneurysms <2 cm in diameter. 2

Imaging Modality Selection

  • Ultrasound or CT are both acceptable modalities for surveillance 1, 2
  • Doppler ultrasound is non-invasive and avoids radiation exposure 2
  • CT provides superior anatomic detail if ultrasound is inadequate 1

Surveillance Endpoints - Intervene If:

  • Aneurysm grows to ≥2.0 cm 1, 3
  • Growth rate exceeds 0.5 cm/year 4
  • Patient becomes symptomatic (upper abdominal pain) 1, 3
  • Patient becomes pregnant or plans pregnancy 1, 3
  • Patient requires liver transplantation 1

Special Considerations and Pitfalls

High-Risk Populations Requiring Closer Monitoring

Even at 1 cm, certain patient populations warrant more aggressive surveillance or earlier intervention:

  • Women of childbearing age: Maternal mortality from rupture during pregnancy approaches 70%, with fetal mortality >90% 1
  • Patients with portal hypertension: Increased rupture risk, though specific data for small aneurysms is limited 1, 2
  • Patients awaiting liver transplantation: Should undergo prophylactic treatment even for smaller aneurysms 1

False vs. True Aneurysms

All false (pseudo) aneurysms should be treated regardless of size due to their higher rupture potential and faster growth rate. 3, 4 Ensure imaging clearly distinguishes between true and false aneurysms, as this fundamentally changes management.

Evidence Quality Note

The guidelines for visceral aneurysms are based primarily on Level B evidence (observational studies and case series), as randomized trials are not feasible for these rare lesions. 1 The 2 cm threshold represents consensus based on natural history studies showing acceptable rupture rates below this size in non-high-risk patients. 1, 2

Practical Algorithm

  1. Confirm diagnosis with quality cross-sectional imaging (CT or ultrasound) 1, 2
  2. Assess patient risk factors: pregnancy status/plans, liver disease, portal hypertension 1
  3. If low-risk patient with 1 cm aneurysm: Surveillance imaging every 2-3 years 2
  4. If high-risk patient: Consider annual surveillance or prophylactic treatment at lower threshold 1, 3
  5. Intervene if: Size ≥2 cm, growth ≥0.5 cm/year, symptoms develop, or high-risk status changes 1, 3, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Aneurysms of the splenic artery - a review.

The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.